REG - Tavistock Investment - Statement re press speculation

Tavistock InvestmentsAnnouncement

28/06/2024 10:30

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240628:nRSb3648Ua&default-theme=true

RNS Number : 3648U  Tavistock Investments PLC  28 June 2024

Prior to publication, the information contained within this announcement was
deemed by the Company to constitute inside information as stipulated under the
UK Market Abuse Regulation. With the publication of this announcement, this
information is now considered to be in the public domain.

 

 

Tavistock Investments plc

("Tavistock", the "Company" or the "Group")

 

Statement re press speculation

28 June 2024

 

The Board of Tavistock notes the recent media speculation and confirms that it
is considering a number of potential transactions including a possible
disposal of part of the Group's business to Saltus, a financial planning and
investment management services group. There can be no guarantee that such a
transaction will be concluded, and the Board will only proceed with such a
transaction if it considers it to be in the best interests of the Company and
its shareholders.

 

The Company will make further announcements if and when appropriate.

 

For further information:

 

 Oliver Cooke                                               Tel: 01753 (Tel:01753) 867000

 Brian Raven

 Allenby Capital Limited                              Tel: 020 3328 5656

 (Nominated adviser and broker to Tavistock)

 Corporate Finance:

 Nick Naylor, Liz Kirchner, Daniel Dearden-Williams

 Sales and Corporate Broking:

 Tony Quirke

 Powerscourt

 Gilly Lock                                           Tel: 07711 380 007

 Justin Griffiths                                            020 7250 1446

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  SPCUWAKRSVUNURR